Ausgabe 2/2012
Inhalt (45 Artikel)
Adjuvant bisphosphonate treatment for breast cancer: Why did something so elegant become so complicated?
Mark Clemons, Kent Russell, Luis Costa, Christina L. Addison
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
Caitlin C. Murphy, L. Kay Bartholomew, Melissa Y. Carpentier, Shirley M. Bluethmann, Sally W. Vernon
Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies
D. Aune, D. S. M. Chan, A. R. Vieira, D. A. Navarro Rosenblatt, R. Vieira, D. C. Greenwood, T. Norat
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
Bisrat G. Debeb, Evan N. Cohen, Kimberly Boley, Erik M. Freiter, Li Li, Fredika M. Robertson, James M. Reuben, Massimo Cristofanilli, Thomas A. Buchholz, Wendy A. Woodward
Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
Ziyan Yuan Pessetto, Ying Yan, Tadayoshi Bessho, Amarnath Natarajan
Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer
Alaa T. Alshareeda, Emad A. Rakha, Christopher C. Nolan, Ian O. Ellis, Andrew R. Green
SGK3 is associated with estrogen receptor expression in breast cancer
Jun Xu, Ma Wan, Quanyuan He, Roland L. Bassett Jr, Xiaoyong Fu, Albert C. Chen, Fengtao Shi, Chad J. Creighton, Rachel Schiff, Lei Huo, Dan Liu
Analysis of KLLN as a high-penetrance breast cancer predisposition gene
Ella R. Thompson, Kylie L. Gorringe, David Y. H. Choong, Diana M. Eccles, Gillian Mitchell, Ian G. Campbell
Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
Jun Tang, Rong Deng, Rong-Zhen Luo, Guo-Ping Shen, Mu-Yan Cai, Zi-Ming Du, Shan Jiang, Ming-Tian Yang, Jian-Hua Fu, Xiao-Feng Zhu
Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer
Tobias J. Grob, Uwe Heilenkötter, Stefan Geist, Peter Paluchowski, Christian Wilke, Fritz Jaenicke, Alexander Quaas, Waldemar Wilczak, Matthias Choschzick, Guido Sauter, Annette Lebeau
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter
V. Bartella, P. Rizza, I. Barone, D. Zito, F. Giordano, C. Giordano, S. Catalano, L. Mauro, D. Sisci, M. L. Panno, S. A. W. Fuqua, S. Andò
Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies
Albert C. Chen, Ilenia Migliaccio, Mothaffar Rimawi, Sara Lopez-Tarruella, Chad J. Creighton, Suleiman Massarweh, Catherine Huang, Yen-Chao Wang, Surinder K. Batra, M. Carolina Gutierrez, C. Kent Osborne, Rachel Schiff
Mechanisms of cardiotoxicity associated with ErbB2 inhibitors
Carmine Fedele, Gennaro Riccio, Angela Eliana Malara, Giuseppe D’Alessio, Claudia De Lorenzo
Therapeutic potential for phenytoin: targeting Nav1.5 sodium channels to reduce migration and invasion in metastatic breast cancer
Ming Yang, David J. Kozminski, Lindsey A. Wold, Rohan Modak, Jeffrey D. Calhoun, Lori L. Isom, William J. Brackenbury
Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program
Michael Bilous, Adrienne L. Morey, Jane E. Armes, Richard Bell, Peter H. Button, Margaret C. Cummings, Stephen B. Fox, Glenn D. Francis, Brigid Waite, Glenda McCue, Wendy A. Raymond, Peter D. Robbins, Gelareh Farshid
Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland
Ezequiel Calvo, Van Luu-The, Pascal Belleau, Céline Martel, Fernand Labrie
Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells
Hsiao-Ching Chuang, Naval Kapuriya, Samuel K. Kulp, Ching-Shih Chen, Charles L. Shapiro
Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique
M. Takada, M. Sugimoto, S. Ohno, K. Kuroi, N. Sato, H. Bando, N. Masuda, H. Iwata, M. Kondo, H. Sasano, L. W. C. Chow, T. Inamoto, Y. Naito, M. Tomita, M. Toi
AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies
Cynthie Wong, Xin Wang, David Smith, Kaladhar Reddy, Shiuan Chen
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study
Lawrence J. Solin, Robert Gray, Lori J. Goldstein, Abram Recht, Frederick L. Baehner, Steven Shak, Sunil Badve, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, George W. Sledge Jr., Joseph A. Sparano
Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide
Jennifer Gjerde, Sara Gandini, Aliana Guerrieri-Gonzaga, Line L. Haugan Moi, Valentina Aristarco, Gunnar Mellgren, Andrea DeCensi, Ernst A. Lien
Expression of activated type I receptor tyrosine kinases in early breast cancer
Melanie Spears, Hans Christian Pederson, Nicola Lyttle, Claire Gray, Mary Anne Quintayo, Lyndsay Brogan, Jeremy St. J Thomas, Gillian R. Kerr, Wilma J. L. Jack, Ian H. Kunkler, David A. Cameron, Udi Chetty, John M. S. Bartlett
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy
William Jacot, Stéphane Pouderoux, Simon Thezenas, Angélique Chapelle, Jean-Pierre Bleuse, Gilles Romieu, Pierre-Jean Lamy
Early breast cancer with positive margins: excellent local control with an upfront brachytherapy boost
Thomas M. Schroeder, Ben Liem, Sagus Sampath, William R. Thompson, Janet Longhurst, Melanie Royce
Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer
Ivana Sestak, Michelle Harvie, Anthony Howell, John F. Forbes, Mitch Dowsett, Jack Cuzick
Sentinel lymph node biopsy of the internal mammary chain in breast cancer
E. L. Postma, S. van Wieringen, M. G. Hobbelink, H. M. Verkooijen, H. J. G. D. van den Bongard, I. H. M. Borel Rinkes, A. J. Witkamp
HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases
Han Zhang, Guoping Ren, Xiaoling Wang, Jing Zhao, Hongtian Yao, Yanfeng Bai, Wang Bo
TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer
Joseph A. Sparano, Lori J. Goldstein, Nancy E. Davidson, George W. Sledge Jr., Robert Gray
Feasibility of a randomized controlled trial of vitamin D vs. placebo in women with recently diagnosed breast cancer
David W. Cescon, Patricia A. Ganz, Samantha Beddows, Marguerite Ennis, Barbara K. Mills, Pamela J. Goodwin
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis
Saroj Niraula, Alberto Ocana, Marguerite Ennis, Pamela J. Goodwin
Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease
Xuefen Su, Graham A. Colditz, Laura C. Collins, Heather J. Baer, Laura A. Sampson, Walter C. Willett, Catherine S. Berkey, Stuart J. Schnitt, James L. Connolly, Bernard A. Rosner, Rulla M. Tamimi
Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer
Maria E. C. Sandberg, Mikael Hartman, Daniel Klevebring, Sandra Eloranta, Alexander Ploner, Per Hall, Kamila Czene
Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among black and white women
Kerryn W. Reding, Christopher S. Carlson, Orsalem Kahsai, Christina C. Chen, Andrew McDavid, David R. Doody, Chu Chen, India Ornelas, Kimberly Lowe, Leslie Bernstein, Linda Weiss, Jill A. McDonald, Michael S. Simon, Brian Strom, Polly A. Marchbanks, Ronald Burkman, Robert Spirtas, Jonathan M. Liff, Kathleen E. Malone
Serum cotinine and prognosis in breast cancer
L. Johnson, O. Agbaje, M. Doig, I. S. Fentiman
The economic burden of metastatic breast cancer: a U.S. managed care perspective
Alberto J. Montero, Sara Eapen, Brian Gorin, Paulette Adler
Adult weight gain, fat distribution and mammographic density in Spanish pre- and post-menopausal women (DDM-Spain)
Marina Pollán, Virginia Lope, Josefa Miranda-García, Milagros García, Francisco Casanova, Carmen Sánchez-Contador, Carmen Santamariña, Pilar Moreo, Carmen Vidal, Mercé Peris, María Pilar Moreno, José Antonio Vázquez-Carrete, Francisca Collado, Carmen Pedraz-Pingarrón, Nieves Ascunce, Dolores Salas-Trejo, Nuria Aragonés, Beatriz Pérez-Gómez, Francisco Ruiz-Perales
Incidence of invasive breast cancer in the presence of competing mortality: the Canadian National Breast Screening Study
Sharareh Taghipour, Dragan Banjevic, Joanne Fernandes, Anthony B. Miller, Neil Montgomery, Bart J. Harvey, Andrew K. S. Jardine
Long-term survival of older breast cancer patients: population-based estimates over three decades
Bindu Kanapuru, William B. Ershler, Charles Hesdorffer, Ahmedin Jemal, Jerome W. Yates
The influence of mammographic density on breast tumor characteristics
Louise Eriksson, Kamila Czene, Lena Rosenberg, Keith Humphreys, Per Hall
The influence of non-clinical patient factors on medical oncologists’ decisions to recommend breast cancer adjuvant chemotherapy
T. May Pini, Sarah T. Hawley, Yun Li, Steven J. Katz, Jennifer J. Griggs
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010
Erika A. Waters, Timothy S. McNeel, Worta McCaskill Stevens, Andrew N. Freedman
NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup
Michael Retsky, Rick Rogers, Romano Demicheli, William JM Hrushesky, Isaac Gukas, Jayant S. Vaidya, Michael Baum, Patrice Forget, Marc DeKock, Katharina Pachmann
Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry
Jing Zhang, James D. Fackenthal, Yonglan Zheng, Dezheng Huo, Ningqi Hou, Qun Niu, Cecilia Zvosec, Temidayo O. Ogundiran, Anselm J. Hennis, Maria Cristina Leske, Barbara Nemesure, Suh-Yuh Wu, Olufunmilayo I. Olopade
High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?
Miriam J. Smith, Franchesca L. Gifford, Fiona Lalloo, William G. Newman, D. Gareth R. Evans
A bias in genotyping the miR-27a rs895819 and rs11671784 variants
Rongxi Yang, Barbara Burwinkel